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Abstract
Background: Single-cell sequencing enables us to better understand genetic diseases, such as cancer or
autoimmune disorders, which are often affected by changes in rare cells. Currently, no existing software is aimed at
identifying single nucleotide variations or micro (1-50 bp) insertions and deletions in single-cell RNA sequencing
(scRNA-seq) data. Generating high-quality variant data is vital to the study of the aforementioned diseases, among
others.
Results: In this study, we report the design and implementation of Red Panda, a novel method to accurately
identify variants in scRNA-seq data. Variants were called on scRNA-seq data from human articular chondrocytes,
mouse embryonic fibroblasts (MEFs), and simulated data stemming from the MEF alignments. Red Panda had the
highest Positive Predictive Value at 45.0%, while other tools—FreeBayes, GATK HaplotypeCaller, GATK
UnifiedGenotyper, Monovar, and Platypus—ranged from 5.8–41.53%. From the simulated data, Red Panda had the
highest sensitivity at 72.44%.
Conclusions: We show that our method provides a novel and improved mechanism to identify variants in scRNAseq as compared to currently existing software. However, methods for identification of genomic variants using
scRNA-seq data can be still improved.
Keywords: Red panda, Variant calling using scRNAseq, Single cell sequencing, Human articular chondrocytes,
Heterozygous variant calling

Background
Single-cell sequencing (SCS) is a relatively new technique that saw its first use in 2011 [1] and has been used
to investigate important biological problems: examining
the heterogeneity of different cancers [2], determining
copy number variation in enhanced detail [3], and better
characterizing circulating tumor cells using differential
expression analysis [4, 5]. Multiple recent studies using
SCS have also shown that tumors are genetically diverse
* Correspondence: babu.guda@unmc.edu
Department of Genetics, Cell Biology and Anatomy, University of Nebraska
Medical Center, Omaha, NE 68198, USA

and produce subclones that contribute to the pathogenicity of the disease by conferring chemotherapy resistance and metastatic capabilities to the tumor [6, 7]. This
technology has also proven useful by aiding in characterizing somatic mutations in neurons [8], identifying rare
intestinal cell types [9], and discriminating cell types in
healthy tissues [10, 11].
One area that has not been widely explored is the detection of small variants in SCS. Single Nucleotide Variants (SNVs) and micro (1-50 bp) insertions and
deletions (indels) can have a large impact on human disease [12–14] and are typically identified using exome
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sequencing or whole-genome sequencing (WGS) [15].
There are few available tools for SNVs identification,
which will work for bulk RNA-seq data [16, 17]. Monovar has been developed to identified variants in scDNAseq [18], but there exists no companion tool for scRNAseq. An effort has been made to apply best practices for
identifying variants in RNA-seq to scRNA-seq datasets
[8, 19], but they do not take advantage of the unique nature of the data produced by the scRNA-seq platform.
This study introduces a novel method, Red Panda, that
is designed specifically to identify variants in single-cell
RNA sequencing (scRNA-seq) and tests how it compares
to currently-available variant callers: FreeBayes [20],
GATK HaplotypeCaller [21], GATK UnifiedGenotyper
[22], Platypus [23], and Monovar [18]. The first four
tools were originally developed for calling variants using
bulk DNA sequencing data but can also identify variants
in bulk mRNA sequencing data. For our purposes, data
from scRNA-seq, as opposed to scDNA-seq, is used as it
largely avoids errors stemming from single-cell genomic
sequencing—high allelic dropout, coverage nonuniformity leading to lack of coverage in exons, and False Positive (FP) amplification errors [24].
Red Panda employs the unique information found in
scRNA-seq to increase accuracy as compared to software designed for bulk sequencing. We utilize the fact that transcripts represented by scRNA-seq reads necessarily only
originate from the chromosomes present in a single cell.
Where applicable, this fact is used to decide what is and is
not a heterozygous variant. For example, if 20% of the transcripts of a gene originate from the maternal chromosome
and 80% originate from the paternal, then all the heterozygous variants of that gene in the expressed transcript will be
represented at a reference to alternate allele ratio of either 1:
4 or 4:1. In other words, all the heterozygous variants in that
transcript are expected to be part of a bimodal distribution,
which can be exploited to improve the accuracy of variant
calling using scRNA-seq data. Such unique information
could not be obtained from bulk sequencing, where each
variant is independently called. As part of the process of
identifying variants, Red Panda creates three different classes:
homozygous-looking, bimodally-distributed heterozygous,
and non-bimodally-distributed heterozygous. We use simulated and experimental data to prove that this partitioning
strategy, as well as treating bimodally-distributed variants differently, leads to an increase in sensitivity and Positive Predictive Value (PPV) compared to currently available
methods. A preprint of Red Panda is available at https://
www.biorxiv.org/content/10.1101/2020.01.08.898874v2 [25].

Methods
Data generation and quality control

For algorithm development, human articular chondrocytes were sequenced using the Smart-seq2 protocol for
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single cells (Supplemental Fig. 1). These data satisfied five
criteria needed for a test dataset: (i) bulk genomic sequencing data paired with scRNA-seq data generated from
Smart-seq2 libraries, (ii) isogenic tissue, (iii) high quality
sequencing data, (iv) the sequencing data must be from an
organism with a well-annotated genome, (v) the sequencing data must come from normal cells. The first criterion
was especially important because the bulk sequencing data
was used to corroborate the findings from the scRNA-seq
data. For this dataset, 30 live cells successfully captured
from a 96 chamber C1 Fluidigm IFC were sequenced and
eight were removed due to: low read count, too many
reads originating outside exons (percentage of reads outside exons is one standard deviation above the median
percentage of reads outside exons for all samples), and/or
transcription profiles not correlating with the other cells
sequenced (Pearson’s Correlation: p > 0.05; Supplemental
Figs. 2 & 3 and Supplemental Table 1).
Additionally, 56 mouse embryonic fibroblasts (MEFs) were
sequenced using the Smart-seq2 protocol and are paired
with Sanger sequencing for validation. Simulated data were
generated from the MEF alignment files for each sample
(Supplemental Fig. 4). Of these, one cell was removed due to
its low read counts, too many reads originating outside
exons, and transcription profiles not correlating with the
other cells sequenced (Supplemental Figs. 5 & 6).
Exome sequencing

We performed cell prep, and DNA extraction on human
articular chondrocytes harvested the same day from the
same batch as the single-cell capture. Genomic DNA was
extracted using the QIAGEN DNA extraction kit per
manufacturer’s instructions. Due to the low amount of
DNA captured (80 ng), 12 PCR amplification cycles were
performed prior to library preparation to obtain enough
DNA. The Agilent SureSelect Clinical Research Exome V2
kit was used to capture coding regions and generate a library. The exome library was sequenced on two lanes of
the NextSeq500 using 75 base pair paired-end sequencing.
Whole exome sequencing statistics of the articular chondrocyte are provided in Supplemental Table 2.
Exome variant calling

The bcbio-nextgen v. 1.0.3 pipeline was used for variant
calling to align reads and identify variants in the exome.
Reads were aligned to the human genome v. 38 (hg38)
using BWA-MEM v. 0.7.15. FreeBayes (v. 1.1.0), GATK
HaplotypeCaller (v. 3.7.0), and Platypus (v. 0.8.1) were
used to identify SNVs and indels. Only those variants
identified by at least two out of the three algorithms
were kept (Supplemental Table 3). MultiQC v. 1.0.dev0
was run to aggregate Quality Control (QC) statistics
from bcbio-nextgen, samtools v. 1.4, bcftools v. 1.4, and
FastQC v. 0.11.5.
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Single-cell RNA sequencing
Human articular chondrocytes

Articular chondrocytes were harvested from a Caucasian female patient undergoing total knee replacement, who provided informed consent under IRB
#691–13-EP prior to the study. Cells were extracted
from shavings of articular cartilage, all of which was
consumed in the generation of the scRNA-seq and
exome libraries. This was done through sequential digestion in .2% Pronase (Roche) for 2 h, followed by
overnight digestion in .2% collagenase (Gibco), all
while shaking at 37 °C. Cell suspensions were passed
through 70 μM cell strainers (BD Falcon) and centrifuged at 500xG for 10 min to recover chondrocytes.
The cells were subsequently embedded in threedimensional alginate bead cultures at a final concentration of about 75 million cells per mL. The cultures
were maintained at 37 °C in a 5% CO2 atmosphere in
Dulbecco’s modified Eagle medium (DMEM)/F12 (1:1)
supplemented
with
1%
penicillin-streptomycinglutamine (Invitrogen, 10,378–016), Amphotericin B
(Gibco, 15,290,026), insulin-transferrin-sodium selenite
(Sigma, I2771), 50 μg/mL Vitamin C, 10 ng/mL FGF2,
and 10 ng/mL TGF-bb3 (PeproTech®, 100-36E) for 14
days. The day before single-cell capture, cells were
lysed using Trizol® reagent (Life Technologies) according to the manufacturer’s protocol. These cells
were split into two groups for DNA and RNA extraction. Cells were loaded onto a 10–17 μm Fluidigm C1
Single-Cell Auto Prep IFC, and the cell-loading script
was performed using the manufacturer’s instructions.
Each of the 96 capture sites was inspected under a
confocal microscope to remove sites containing dead
cells (as identified by the LIVE/DEAD Cell Viability
Assay) and to remove capture sites containing more
than one cell. Cells that were not identified as either
alive or dead by the LIVE/DEAD assay were retained
for RNA sequencing. Summary of the human articular
chondrocytes captured on the Fluidigm C1 is available
in Supplemental Table 4. Following capture, reverse
transcription and cDNA amplification were performed
in the C1 system using the Clontech SMARTer Ultra
Low Input RNA Kit for Sequencing v3 per the manufacturer’s instructions. Amplification was performed
using the Nextera XT DNA Sample Preparation Kit,
and the Nextera XT DNA Sample Preparation Index
Kit (Illumina) was used for indexing. After quantification using an Agilent Bioanalyzer, sequencing was
performed on two lanes of the NextSeq500 using 150
base pair paired-end sequencing.
Mouse embryonic fibroblasts

Mouse embryonic fibroblasts (MEFs) were harvested from
embryos at E13.5 and extracted using previously
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standardized methods [26]. After isolation, cells were cultured in DMEM containing 10% FBS and 1% of each penicillin and streptomycin at 37 °C in a 5% CO2 atmosphere
for 2 days. On the day of single-cell capture, cells were
trypsinized (0.05% Trypsin-EDTA solution), counted, and
resuspended in media at 105 cells/mL concentration. Sequencing was performed as described above.
Single-cell RNA variant calling

The bcbio-nextgen v. 1.0.3 pipeline for RNA-seq was
used to align reads and perform transcript quantification
for each cell. Reads were aligned using hisat2 v. 2.1.0 to
be used in the downstream analysis for FreeBayes,
GATK HaplotypeCaller, GATK UnifiedGenotyper,
Monovar, and Red Panda. However, for Platypus, BWAMEM v. 0.7.15 was used to align reads due to Platypus’s
inability to process reads split across long distances. The
genome hg38 was used for the human articular chondrocytes, and mm10 was used for the MEFs. All four bulk
variant callers were run using default parameters with a
few exceptions. For FreeBayes, min-alternate-fraction
was set to 0.1 and no-partial-observations was enabled,
and GATK HaplotypeCaller and GATK UnifiedGenotyper set standard minimum confidence threshold for calling to 4.0. Sailfish v. 0.10.1 was used to generate
expression values. MultiQC v. 1.0.dev0 was run to aggregate QC statistics from bcbio-nextgen, samtools v. 1.4,
QualiMap v. 2.2.2a53, and FastQCv. 0.11.5.
Sanger sequencing

Primer3Plus (Supplemental Table 5) was used to create
target regions for Sanger sequencing. For the first round
of sequencing, the PCR reaction was performed using
GoTaq Hot Start Polymerase following the manufacturer’s protocol with an annealing temperature (Tm) of
50 °C. After amplification, PCR products were run on
1.5% agarose gel and visualized in Kodak gel doc, and
specific DNA bands were recovered using QIAquick Gel
Extraction Kit. For the second round of sequencing of
the Red Panda-specific variants, a 55 °C Tm was used,
followed by running the PCR products on 2% agarose
gel. Purified DNA products paired were submitted to
Genewiz for Sanger sequencing.
Statistic calculations

For our calculations, (i) a True Positive (TP) is a position
on the genome that is correctly identified as differing
from the reference genome, (ii) a True Negative (TN) is
a position on the genome that is correctly identified as
not differing from the reference, (iii) a False Positive
(FP) is a position on the genome that is incorrectly identified as differing from the reference, (iv) a False Negative (FN) is a position on the genome that is incorrectly
identified as not differing from the reference genome.
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Sensitivity ¼ TP=ðTP þ FN Þ

Positive Predictive Value ðPPV Þ ¼ TP=ðTP þ FPÞ
Software requirements and distribution

Red Panda, written almost entirely in Perl, relies on samtools mpileup and GATK HaplotypeCaller to function.
The tool mpileup is required to generate a list of every
variant in a sample. GATK HaplotypeCaller is necessary
to call heterozygous variants that do not fit a bimodal
distribution. Bedtools, vcf-sort found in the vcftools
package, and Picard Tools are all necessary to manipulate the different types of files used during the variant
calling process. As these tools are all supported by different institutions under different licenses, Red Panda
does not come prepackaged with them.
Red panda algorithm

Red Panda takes two files as input: a tab-delimited file
generated by sailfish [27] containing a list of all isoforms
and their expression levels in a cell and also a Variant
Call Format (VCF) file generated by samtools mpileup
[28] containing a pileup of all locations in the cell’s genome that differ from the reference. The second file is the
list of all putative variants from which Red Panda will
create three lists: homozygous-looking, bimodallydistributed heterozygous, and non-bimodally-distributed
heterozygous variants.
The distinction between heterozygous variants and
homozygous-looking variants is necessary, because variants will either have a fraction of reads that support an
unambiguously heterozygous variant, or they will have a
fraction of reads that, in a single cell, appears to be a
homozygous variant, but could potentially be heterozygous. This is due to the stochastic nature of RNA transcription leading to allele-specific expression [29–31].
This monoallelic expression can lead to a heterozygous
variant looking like a homozygous variant [32, 33]. Due
to this ambiguity, variants that have full read coverage
supporting an alternate allele are hereafter termed
“homozygous-looking” rather than “homozygous”. The
workflow for this methodology can be found in Fig. 1.
Red Panda capitalizes on the fact that read data come
from a single cell, so transcripts represented by the
scRNA-seq reads necessarily come from the two chromosomes present. It is this information that we factor
that into our decision-making process when establishing
what is and is not a variant. In a diploid cell, one would
expect transcripts to originate from two chromosomes,
and thus, any heterozygous variant present in a given
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transcript will be represented in the sequencing data by
a fraction consistent with the fraction of transcripts
coming from a specific chromosome. Figure 2 shows
that if 30% of the transcripts for a gene in a cell originate
from the maternal chromosome and 70% from the paternal chromosome, then reads in the scRNA-seq data will
represent every heterozygous variant present in that
transcript at either a 7:3 ratio (reference: alternate allele)
or a 3:7 ratio. This type of variant is considered to be
bimodally-distributed heterozygous and any variant on
the same transcript that’s falling outside of this distribution with a tolerance of 5% is likely to be a False Positive.
Using this concept, Red Panda can accurately remove
False Positive heterozygous variant calls—often artifacts
from the library preparation, sequencing, or alignment—
as well as identify variants supported by even a low fraction of reads that the current tools would not be able to
capture (Supplemental Fig. 7).
The above described bimodally-distributed heterozygous
variants are processed from the VCF file generated by
samtools mpileup. This file is split into two lists containing variants that are heterozygous or homozygouslooking. Heterozygous variants are filtered into two files:
one containing the aforementioned bimodally-distributed
variants and one containing the non-bimodallydistributed variants, the latter of which is filtered by
GATK HaplotypeCaller as there is no unique information
that Red Panda can capitalize on. GATK HaplotypeCaller
is used because it has been proven to be among the most
accurate variant callers available [34].
The final list of variants that is presented to the user
contains those that: are heterozygous and fit a bimodal
distribution, are heterozygous and did not fit a bimodal
distribution but were supported by GATK HaplotypeCaller, and those that appeared to be homozygous and
had a read depth of at least 10x. This method of partitioning variants is also used for indels.
Red Panda runs on a single core but can easily be parallelized by being run on a cluster. Each cell, each with
~ 5.4 million reads, takes, on average, two hours to
complete the analysis.
Simulation

Roughly 1000 simulated variants were programmatically
inserted into the alignments generated from the MEFs
resulting in a unique set of simulated variants for each
cell. Of these, 650 were homozygous, and ~ 350 were heterozygous, a subset of which ~ 70 were bimodallydistributed. These numbers were used because they are
close to the proportions seen in the variants corroborated
by the exome sequencing in the articular chondrocyte data.
While these proportions do not match those expected
based on bulk sequencing experiments [35–37], they do
match what is expected from scRNA-seq data [19].

Cornish et al. BMC Genomics 2020, 21(Suppl 11):830
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Fig. 1 A simple schematic of the logic used in Red Panda. For every cell, every expressed isoform is identified with sailfish. All putative variants
are then identified in each isoform and split into a homozygous-looking VCF file and a heterozygous VCF file. Then the former is filtered by Red
Panda using quality cutoffs while the latter is filtered using Red Panda if the variants are bimodally-distributed or GATK-HC if they are not. These
three sets of variants are then combined into a single VCF file

To instill a level of uniformity, a list of locations
was randomly selected from the alignment files where
there was a read depth of at least 20x (Supplemental
Fig. 8). The positions on the genome where the 650
homozygous and 280 non-bimodally-distributed heterozygous variants were inserted were not restricted
except that they must originate from the locations
with at least 20x read coverage. Conversely, the
bimodally-distributed heterozygous variants had additional parameters determining their placement. They
were required to have a minimum of two variants
placed in an expressed (TPM > 1) isoform. From the
MEF sequence data, an average of ~ 3 (a range of 2–
5) variants per isoform were observed resulting in 23
randomly chosen genes being used for this class of
variant. For each isoform, 2–5 variants were randomly
inserted into the gene but only if more than 250 bp
of viable (read depth > = 20x) locations existed.

Results
Comparison of different tools using human articular
chondrocytes

Alignment files generated for each of the 22 chondrocyte
scRNA-seq samples were used as input for FreeBayes,
GATK HaplotypeCaller, GATK UnifiedGenotyper, Monovar, Platypus, and Red Panda. The variant calls generated
by each tool were cross-referenced with the variants found
in the exome to determine their veracity. To avoid False
Negatives, comparisons were restricted to locations supported by alignments in both the exome and the cell being
compared. To evaluate the ability of each method, the
number of variants found in concordance with the exome
as well as the PPV for each tool were calculated.
Figure 3a shows that, on average, Red Panda identifies
913 variants per cell that are in accordance with the exome whereas FreeBayes identifies 65, GATK HaplotypeCaller 705, GATK UnifiedGenotyper 222, Monovar 861,

Cornish et al. BMC Genomics 2020, 21(Suppl 11):830
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Fig. 2 Finding a bimodal distribution. Any variants (green box) that fit into the expected distribution of reads stay. Any that do not are removed:
here the variant existing at a fraction of 0.5 (red box) would be removed

and Platypus 386. There is a consistent overlap between
the tools, even for FreeBayes and GATK UnifiedGenotyper which typically did not identify as many variants as
the other tools (Supplemental Fig. 9). While Red Panda
shares significant overlap with the other tools, it also
identifies a large number of unique variants by itself.
To assess the effectiveness of these variant callers with
regards to heterozygous variant identification, the same
analysis was performed using just the heterozygous
SNVs and indels in each sample. Each tool has its own
annotation dictating if a variant is heterozygous, and
these variants were cross-referenced with the exome sequencing data to confirm the variants were, in fact,
heterozygous.
Figure 3b shows the total number of heterozygous
SNVs and indels in concordance with the exome for
each tool and each cell. Percent of variants that are

heterozygous and validated by GATK-HC, and heterozygous and validated by Red Panda are provided in Supplemental Table 6. On average, 154 variants in agreement
with the exome were identified by Red Panda, 31 by
FreeBayes, 136 by GATK HaplotypeCaller, 118 by
GATK UnifiedGenotyper, 368 by Monovar, and 36 by
Platypus. PPV and False Discovery Rate (FDR) were calculated (Table 1 and Fig. 3c), and show that Red Panda
has the highest average PPV (44.96%) of any of the tools.

Comparison of different tools using MEFs

The six software packages were compared by assessing the variant overlap between cells. As these cells
were isogenic, each cell should have shared a large
portion of its variants with the other cells sequenced.
This was evaluated with a high overlap identified by a

Cornish et al. BMC Genomics 2020, 21(Suppl 11):830
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Fig. 3 Variants in concordance with the exome and PPV for each tool. a The total number of variants in concordance with the exome for every
cell as identified by each tool. Red Panda is characterized by three box plots: 1, 2, and all. Red Panda_1 contains variants exclusive to Red Panda
logic: homozygous-looking variants and bimodally-distributed heterozygous variants. Red Panda_2 contains non-bimodally-distributed
heterozygous variants that are called by GATK-HaplotypeCaller. Red Panda_all is a superset of the two. b The total number of heterozygous
variants in concordance with the exome for every cell as identified by each tool. Red Panda is characterized by three box plots: 1, 2, and all. Red
Panda_1 contains bimodally-distributed heterozygous variants. Red Panda_2 contains non-bimodally-distributed heterozygous variants. Red
Panda_all is a superset of the two. c The average PPV calculated for each tool

variant caller as an indicator that that software performed well.
Table 2 shows the average number of variants identified with Monovar identifying the highest number of
variants of all the tools. Extrapolating from the PPV results from the articular chondrocyte data, this means
that Monovar also identified the highest number of True
Positives and fewest False Positives.

Overlap of variants between cells was measured by
looking at the all-to-all comparison of 55 cells, resulting
in 1540 unique possible comparisons. Three groups of
variants are assessed in these comparisons: all variants
shared, homozygous-looking variants shared, and heterozygous variants shared (Supplemental Figs. 10 & 11).
Figure 4 shows the distribution of the fraction and a
total number of variants overlapping in the pairwise

Cornish et al. BMC Genomics 2020, 21(Suppl 11):830
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Table 1 PPV and FDR for each tool

where the latter identifies the highest fraction (Fig. 4e)
and highest total number (Fig. 4f) of heterozygous variants shared in pairwise comparisons.

Algorithm

Average PPV (%)

Average FDR (%)

FreeBayes

8.69% ± 0.35%

91.31% ± 0.35%

GATK HaplotypeCaller

31.67% ± 2.08%

68.33% ± 2.08%

GATK UnifiedGenotyper

5.84% ± 0.45%

94.16% ± 0.45%

Validation with sanger sequencing

Monovar

41.53% ± 0.29%

58.47% ± 0.29%

Platypus

6.95% ± 0.49%

93.05% ± 0.49%

Red Panda

44.96% ± 3.15%

55.04% ± 3.15%

Sanger validation was performed on two sets of random
variants found in the MEF sequencing: one set of 20 random variants identified by all variant callers, and one set
of 20 random variants identified exclusively by Red
Panda. The first group is meant to assess the accuracy of
all the tools taken as a whole, and the second is to address whether the Red Panda-specific variants are reliable. One requirement of the variants being validated is
that they were identified in at least two cells. Ideally, variants present in more than 50% of the cells would be
chosen, but as Table 3 shows, there were not enough
variants that are present in even > 22 out of 55 of the
cells to perform validation in this way.
Enough valid sequences were generated for 33 of the 40
targets by Sanger sequencing to validate the presence of
their corresponding variant (Supplemental Tables 7, 8, 9).
Of these 33, only three variants, all of which were exclusively identified by Red Panda, were validated by Sanger
sequencing. In all three instances, the variants were found
in nine or more cells.

The average PPV and FDR with standard deviations for each tool using the
exome as a reference is listed

comparisons for all three classes of variants. Monovar
identifies both the highest fraction of variants shared in
pairwise comparisons, as well as total variants shared.
For Red Panda, the highest fraction and total count of
variants shared in pairwise comparisons come from the
homozygous-looking class wherein more than 75% of
the comparisons achieve a higher fraction of overlap
than every other tool. Interestingly, it is rare for any tool
to have more than 100 heterozygous variants shared between cells.
Validation with simulated data

Sensitivity was calculated for each tool across every cell.
Figure 5 and Supplemental Fig. 12 show that for homozygous variants and bimodally-distributed heterozygous
variants, Red Panda consistently outperforms the other
four tools, resulting in a higher overall sensitivity. For
heterozygous variants taken as a whole, Monovar performs the best of the tools. It is unsurprising then that,
compared to Monovar, Red Panda does not perform as
well in this category because it uses GATK HaplotypeCaller (shown to accurately only a identify few heterozygous variants in this simulation) to validate heterozygous
variants that do not follow a bimodal distribution. In this
instance, GATK HaplotypeCaller and GATK UnifiedGenotyper perform poorly because they both utilize a
feature that considers all samples simultaneously. This
results in inferior performance on a group of samples
where each sample may have a large number of mutations unique to that sample, and for this simulation,
every cell has a ~ 1000 variants unique to it. Red Panda
does not suffer as much from this limitation as it explicitly directs GATK-HC to call variants at specific locations one at a time rather than jointly. However, this can
result in lowered sensitivity for Red Panda as compared
to Monovar on samples that are genetically similar

Discussion
Identification of SNVs and indels is vital in addressing
biological problems with a genetic component. While
variant calling methods exist for samples collected from
bulk sequencing, it is also important to have methods
designed for samples collected from SCS. As shown with
the experimental and simulated data, Red Panda makes
it possible to perform variant detection in scRNA-seq
with higher accuracy as compared to currently available
software. Red Panda gains an advantage against other
tools by intentionally separating variants into three separate classes and processing them differently:
homozygous-looking, bimodally-distributed heterozygous, and non-bimodally-distributed heterozygous.
Using the exome variant data from bulk sequencing as
a reference, Red Panda outperforms the other software.
It provides both the highest PPV (45% - Table 1) of any
of the tools as well as the highest number of variants in
concordance with the exome (913 on average - Fig. 3a).
However, PPV is still low compared to using bulk sequencing data [34, 38].

Table 2 Average variant count and standard deviation for each tool
FreeBayes

GATK-HC

GATK-UG

Monovar

Platypus

Average

865.8

611.1

574.7

3515.44

315.4

1071.8

Stdev

235.3

195.1

170.5

834.04

107.1

372.6

For this analysis, the total number of variants identified by each tool is reported

Red Panda
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a

b

c

d

e

f

Fig. 4 Violin plots for variants shared between cells. Violin plots show the fraction (left) and quantitative (right) overlap for a, b all variants, c, d
homozygous-looking variants, and e, f heterozygous variants shared in every pairwise cell comparison

In the MEF sequencing analysis, Red Panda performs
better than the four bulk variant callers by identifying the
highest number of variants per cell, but does fall short of
the total identified by Monovar (Table 2). This could be
explained by the fact that Red Panda is designed to work
solely on data from individual cells, while Monovar gains
an advantage by using variant data from all cells in the
sample to calculate a posterior probability for making
more confident variant calls. Surprisingly, both Monovar
(3515) and FreeBayes (865) identified a much higher number of variants (Table 2) as compared to the results from
the human articular chondrocyte data (Fig. 3a). The

FreeBayes results are especially unexpected where it had
the fewest number of variants shared between the scRNAseq results and the exome (Fig. 3a). One explanation may
be that while FreeBayes identifies a high number of variants, the majority of those are False Positives. This idea is
supported by the PPV for FreeBayes from the articular
chondrocyte data (Fig. 3c).
The pairwise cellular comparisons (Fig. 4) assessed
whether each variant caller performed well based on the
consistency of their calls or if they performed poorly,
randomly identifying variants in each cell, because, presumably, the same variants should exist in all 55
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Fig. 5 Sensitivity for identifying simulated variants for each tool. The violin plots of the sensitivity, calculated for each cell using each class of
simulated variants are shown: a all variants, b homozygous variants, c all heterozygous variants, and d bimodally-distributed variants

Table 3 Breakdown by tool of variants present in more than one cell
Present in:

FreeBayes

GATK-HC

GATK-UG

Platypus

Red Panda

Intersection of all tools

> = 2/55 cells

2922

2463

1991

2947

3159†

96*

> = 5/55 cells

970

894

693

324

1051

18

> = 10/55 cells

416

398

309

161

565

0

> = 23/55 of cells

129

122

84

66

257

0

> = 42/55 of cells

38

24

27

22

98

0

The number of cells in which a variant was found was broken down into five groups: presence in at least 2, 5, 10, 23, or 42 of cells. Additionally, the variants
identified by all tools were checked for their presence in the five groups listed above. The variants submitted for Sanger sequencing were drawn from the two
groups labeled with a cross (†) and an asterisk (*)
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datasets. Red Panda performs extremely well for
homozygous-looking variants, but is average for heterozygous variants when compared to the other tools, especially
Monovar. This is due to the fact that, while Red Panda in
principle confers an algorithmic advantage to identifying
heterozygous variants, the monoallelic nature of gene expression and uneven sequencing coverage depth may preclude the tool from realizing its full potential. The
majority of the heterozygous variants identified are actually evaluated by GATK HaplotypeCaller, since most are
unsupported by a bimodal distribution (Fig. 3b).
The results from the raw number and the fraction of
variants overlapping in these pairwise comparisons show
that Red Panda has higher distributions in both categories. It is possible to have a large number of variants
shared, but also have a smaller fraction of variants
shared between cells as is the case with FreeBayes. This
indicates that there are more potential False Positives in
the data generated by FreeBayes which fits with what
was seen in the articular chondrocyte data (Fig. 3c).
The high fraction of homozygous-looking variants
shared (Fig. 4c) makes sense as it is less likely that allelic
dropout will occur in this class as a result of allelespecific expression making for a more stable population
of variants in the scRNA-seq data. Additionally, it is
likely that it is rare for any tool to have more than 100
heterozygous variants shared between two cells because
of the stochastic nature of allele-specific expression.
It is clearly possible to detect significant variation in
transcripts at the single-cell level, but validating those variants at the DNA level is a big challenge due to the inability to isolate sufficient quantities of DNA from the same
single cell to perform Sanger sequencing. Hence, we relied
on Sanger sequencing performed on a bulk of DNA originating from the population of cells from which we harvested the single cells, which validated only three out of
33 variants tested. It is possible that the variants that failed
validation are: False Positives, private mutations to a very
small subset of cells that couldn’t be captured in the bulk
DNA used from the population of cells, or they could be
errors introduced in the scRNA-seq library preparation
process. Due to these limitations, we relied on the simulated data for MEF cells and paired genomic sequencing
as done with the human articular chondrocytes.
There are a number of methods available to imitate
read counts and expression profiles [39–41] in scRNAseq; however, there currently exist no tools to generate
scRNA-seq reads in silico, making the type of simulation
carried out in this study necessary. We created a more
realistic environment because the artifacts and flaws inherent to scRNA-seq are considered and maintained by
our code. One downside however, is that the dataset
used disallows calculating any accuracy statistics requiring False Positive numbers such as specificity and PPV,
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as the scRNA-seq also contains real variation inherent to
the MEFs that will be picked up by each variant caller.
Based on the results from the simulated data (Fig. 5),
we found that Red Panda proves its advantage in identifying bimodally-distributed variants as well as homozygous variants, a class of variant that saw other tools
struggle. When assessing total heterozygous variants,
Monovar is superior to the other tools. This is somewhat
surprising as Monovar gains a large part of its advantage
in pooling cells together to identify variants, a strategy
that should afford it no advantage given our method of
simulating variants (each cell was assigned 1000 variants
unique to that cell). Another unexpected result was how
well FreeBayes performed given what was seen in the results from the human articular chondrocyte experiment
where FreeBayes identified very few variants in concordance with the list obtained from exome sequencing, but
a clue as to why this is might be found in the results
from GATK-HC and GATK-UG. Both of these perform
similarly to each other in the simulation with the latter
consistently performing slightly better than the former.
When variants were called in the exome to generate a
reference list against which these variants from the
scRNA-seq data could be compared, variants were only
retained if they were identified by at least two of the following three tools: FreeBayes, GATK-HC, and Platypus.
However, if the variants in this reference list were consistently only supported by the latter two, then it follows
that variants identified by FreeBayes in the scRNA-seq
experiment would be filtered out and make it appear as
though FreeBayes identified a low number of True Positives. This is further supported by the fact that Platypus
identifies many more variants in concordance with the
exome than FreeBayes. The simulated data indicate that
FreeBayes has good sensitivity, but identifies a large set
of variants different from both GATK-HC and Platypus.
Given the above, in order to improve the accuracy of
Red Panda, Monovar or a combination of Monovar and
GATK-HC could be used when evaluating nonbimodally-distributed heterozygous variants.
It is important to note that the advantages conferred by
Red Panda are currently limited to scRNA-seq generated
by library-preparation methods that generate full-length
transcripts from cDNA such as Smart-seq2 or Holo-seq
[42], although the latter has not been tested in this study.
As methods such as G&T-seq [43] mature—G&T-seq
produces genomic and transcriptomic sequencing from the
same cell—Red Panda can be further validated using sequencing from the same cell, as opposed to scRNA-seq from
one cell being compared to exome sequencing from a bulk
of cells as was performed with the articular chondrocytes.
This would also address the shortcomings tied with validation via Sanger sequencing which uses material from a bulk
of cells.
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Conclusions
Based on the experimental and simulated data, Red
Panda provides a distinct advantage over other available
software. This improvement comes from its ability to
more accurately predict homozygous-looking and
bimodally-distributed heterozygous variants as compared
to other tools. Due to the unique nature of scRNA-seq
data, one must treat heterozygous variants with special
consideration, and Red Panda provides a custom approach to this class of variants. From these results, it is
clear that due to the inherent nature of RNA expression
patterns in single cells, it is difficult to assess what variants exist with the same accuracy that we can with
standard exome or WGS. Despite this, Red Panda provides a novel method of identifying variants in scRNAseq and performs this function better than variant callers
designed for bulk NGS datasets.
Supplementary Information
The online version contains supplementary material available at https://doi.
org/10.1186/s12864-020-07224-3.
Additional file 1: Supplemental Figure 1. Human articular
chondrocyte sequencing strategy. Exome sequencing was paired with
scRNA-seq for the the primary tissue culture of human articular chondrocytes. The library prep for the single cells was performed using the updated Smart-seq2 protocol. Supplemental Figure 2. The genomic
origin of reads found in each cell. Here one can see what percentage of
reads originate from exons (blue), introns (black) or intergenic space
(green). The cells A3-C1NC, C10-C64, D12-C72, and H7-C46 have significantly more reads originating outside the exonic region than other samples. Supplemental Figure 3. Expression correlation between articular
chondrocytes. Pearson Correlation Coefficient calculated for every possible comparison of cells to each other and the two batches of cells. The
darker the color red, the higher the correlation between each cell.
“pool26” contains reads pooled from 26 cells, A3-C1NC, C10-C64, D12C72, and H7-C46 were removed; “pool30” contains reads pooled from all
30 cells. as well as identify three other cells that do not correlate well
based on their expression patterns: H4-C93NC, G2-C38NC, and E4-C75.
Supplemental Figure 4. The sequencing strategy for the MEFs. The
MEFs have variant calling performed on them with five variant callers as
with the articular chondrocytes. Validation is performed by Sanger sequencing on 40 variants as well as using simulations based on this sequencing data. Supplemental Figure 5. The genomic origin of reads
found in each MEF. Here one can see what percentage of reads originate
from exons (blue), introns (black) or intergenic space (green). The cell C47
is the only cell to have significantly more reads originating outside the
exonic region than other samples. Supplemental Figure 6. Expression
correlation between normal MEFs. Pearson Correlation Coefficient calculated for every possible comparison of cells to each other for the normal
MEFs. The darker the color red, the higher the correlation between each
cell. One can clearly see one cell that fails to correlate will with the other
cells: C07. The bottom block of cells significantly correlates with a high
number of cells and they are therefore retained. Supplemental Figure
7 Proof of concept data in articular chondrocytes. An example of the variations, from gene CWC22, that we find in the scRNA-seq data as compared to the exome. The main area of interest is the coverage track (the
gray histograms). Red corresponds to T and blue corresponds to a C.
When there are two colors, the top color corresponds to the alternate allele. (a) Two hetSNVs found in the cell A7-C6 have reads supporting them
at percentages of 80% (left) and 20% (right). The same hetSNVs are found
in the exome data at 50%. There is also a homozygous variant (middle)
seen in both. (b) One hetSNV found in the same gene at 53% in the cell
A7-C6 is absent in the exome sequencing. This is expected as it does not
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fit the existing biomodal distribution at 80% or 20%. Supplemental Figure 8. Workflow for inserting simulated variants. To assess each tool, ~
1000 simulated variants (650 homozygous, 280 heterozygous, and ~ 70
bimodally-distributed heterozygous) were inserted into the alignments
for each cell. Standard variant calling was then performed using each
tool, and these results were compared to the list of known variants to assess their performance. Supplemental Figure 9. UpSet plots of the
overlap between each tool. The overlap of the variants identified by each
tool can be seen for the cell G1-C37. Each column of the X-axis shows
the overlap between each tool represented by a filled-in dot. For example, the first column indicates that GATK-HC, Monovar, and Red Panda
shared 540 variants, the second shows that Red Panda and Monovar
share 208 variants, the third column indicates that there were 118 variants shared between Platypus, GATK-HC, Monovar, and Red Panda, and
so on. Supplemental Figure 10. The fraction of overlap in variants for
every cell using FreeBayes, GATK HC, and GATK UG. The fraction of overlap for (a-c) FreeBayes, (d-f) GATK-HaplotypeCaller, and (g-i) GATKUnifiedGenotyper when comparing (a, d, g) all variants, (b, e, h) homozygouslooking variants, and (c, f, i) heterozygous variants. Each box in the matrix
is a comparison between two cells. Supplemental Figure 11. The fraction of overlap in variants for every cell using Monovar, Platypus, and Red
Panda. The fraction of overlap for (a-c) Monovar, (d-f) Platypus, and (g-i)
Red Panda when comparing (a, d, g) all variants, (b, e, h) homozygouslooking variants, and (c, f, i) heterozygous variants. Each box in the matrix
is a comparison between two cells. Supplemental Figure 12. Raw
counts of True Positives for each tool. The box plots of the raw number
of True Positives show how well each tool is at identifying variants in the
simulation. Due to advantages gained in identifying homozygous and
bimodally-distributed variants, Red Panda identifies the highest number
of True Positives. Supplemental Table 1. Eight human articular chondrocytes removed for quality reasons. “Too many reads outside exon” is
defined as one standard deviation above the median percentage of reads
aligned outside exons for all samples. Statistically insignificant correlation
coefficient is defined as p > 0.05 for a Pearson correlation coefficient
when comparing the transcription profile of a single cell to the pool of
all 30 cells. Supplemental Table 2. Parameters used to design the
primers used for PCR and Sanger. Parameters with a *were changed from
their defaults to ensure good sequencing. Supplemental Table 3. Human articular chondrocyte exome sequencing statistics. Sequencing and
analysis statistics of the exome data from the human articular chondrocytes. Supplemental Table 4. Human articular chondrocyte exome variant calling statistics. Variant analysis statistics of the exome data from the
human articular chondrocytes using the ensemble approach where 2/3
variant caller tools had to agree to call a variant. Supplemental Table 5.
Summary of the human articular chondrocytes captured on the C1. Supplemental Table 6. Summary table of variants identified by Red Panda
in human articular chondrocytes. Percent of variants that are
homozygous-looking, heterozygous, heterozygous and validated by
GATK-HC, heterozygous and validated by Red Panda are calculated. Average total number of variants in the final VCF file is also shown. Supplemental Table 7. Validation of variants identified by all five variant callers.
In the Validated by Sanger column, N = No, and NS = No Sequence at
that position. Supplemental Table 8. First sequencing pass: Validation
of variants only identified by Red Panda. In the Validated by Sanger column, Y = Yes, N = No, and NS = No Sequence at that position. Supplemental Table 9. Second sequencing pass: Validation of variants only
identified by Red Panda. In the Validated by Sanger column, Y = Yes, N =
No, and NS = No Sequence at that position.

Abbreviations
scRNA-seq: Single-cell RNA sequencing; SCS: Single-cell sequencing;
MEFs: Mouse embryonic fibroblasts; SNVs: Single nucleotide variants;
PPV: Positive predictive value; WGS: Whole-genome sequencing

Acknowledgements
The authors are very grateful to Kristin Wipfler for her valuable input during
algorithm development, Cecily Zdan for copy editing, and Dr. James Eudy
for his valuable input during setup and processing of the sequencing.

Cornish et al. BMC Genomics 2020, 21(Suppl 11):830

About this supplement
This article has been published as part of BMC Genomics Volume 21
Supplement 11 2020: Bioinformatics methods for biomedical data science.
The full contents of the supplement are available at https://bmcgenomics.
biomedcentral.com/articles/supplements/volume-21-supplement-11.
Authors’ contributions
AC designed the study, performed all analyses, and wrote the manuscript.
SR, KS, and SP performed experiments. CG with the help of NKM supervised
the project, provided essential feedback on experimental results and input
on the analyses themselves, and thoroughly edited the manuscript. KB and
AD provided technical guidance and materialistic support for experiments
performed by SR/SP and KS, respectively. All authors read and approved the
final manuscript.
Funding
This work was supported by the development funds to CG, and the Office of
Graduate Studies fellowship to AC, from the University of Nebraska Medical
Center (UNMC) and the NIH award [2P01AG029531] to CG. The University of
Nebraska DNA Sequencing Core and the Bioinformatics and Systems Biology
core receive partial support from the National Institutes of Health grants
[P20GM103427, 1P30GM110768, P30CA036727]. Publication costs are funded
by the development funds to CG from UNMC.
Availability of data and materials
Red Panda is released under the MIT license and can be found on GitHub at
https://github.com/adambioi/red_panda. Manual and source code of the
tools are available in the GitHub repository.

Page 13 of 14

8.

9.

10.

11.

12.

13.

14.

15.

16.
Ethics approval and consent to participate
Articular chondrocytes were harvested from a Caucasian female patient
undergoing total knee replacement, who provided informed consent under
the University of Nebraska Medical Center Institutional Review Board (IRB)
#691–13-EP before the study.

17.
18.

Consent for publication
Not applicable.

19.

Competing interests
The authors declare that the research was conducted in the absence of any
commercial or financial relationships that could be construed as a potential
conflict of interest.

20.

Published: 29 December 2020

22.

References
1. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Cook K,
Stepansky A, Levy D, Esposito D, et al. Tumour evolution inferred by singlecell sequencing. Nature. 2011;472(7341):90–4.
2. Suzuki A, Matsushima K, Makinoshima H, Sugano S, Kohno T, Tsuchihara K,
Suzuki Y. Single-cell analysis of lung adenocarcinoma cell lines reveals
diverse expression patterns of individual cells invoked by a molecular target
drug treatment. Genome Biol. 2015;16:66.
3. McConnell MJ, Lindberg MR, Brennand KJ, Piper JC, Voet T, Cowing-Zitron
C, Shumilina S, Lasken RS, Vermeesch JR, Hall IM, et al. Mosaic copy number
variation in human neurons. Science. 2013;342(6158):632–7.
4. Ramsköld D, Luo S, Wang Y-C, Li R, Deng Q, Faridani OR, Daniels GA,
Khrebtukova I, Loring JF, Laurent LC, et al. Full-length mRNA-Seq from
single-cell levels of RNA and individual circulating tumor cells. Nat
Biotechnol. 2012;30(8):777–82.
5. Ni X, Zhuo M, Su Z, Duan J, Gao Y, Wang Z, Zong C, Bai H, Chapman AR,
Zhao J, et al. Reproducible copy number variation patterns among single
circulating tumor cells of lung cancer patients. Proc Natl Acad Sci U S A.
2013;110(52):21083–8.
6. Gawad C, Koh W, Quake SR. Dissecting the clonal origins of childhood
acute lymphoblastic leukemia by single-cell genomics. Proc Natl Acad Sci U
S A. 2014;111(50):17947–52.
7. Jan M, Snyder TM, Corces-Zimmerman MR, Vyas P, Weissman IL, Quake SR,
Majeti R. Clonal evolution of preleukemic hematopoietic stem cells
precedes human acute myeloid leukemia. Sci Transl Med. 2012;4(149):
149ra118.

21.

23.

24.
25.

26.
27.

28.

29.
30.

Lodato MA, Woodworth MB, Lee S, Evrony GD, Mehta BK, Karger A, Lee S,
Chittenden TW, D'Gama AM, Cai X, et al. Somatic mutation in single human
neurons tracks developmental and transcriptional history. Science. 2015;
350(6256):94–8.
Grün D, Lyubimova A, Kester L, Wiebrands K, Basak O, Sasaki N, Clevers H,
van Oudenaarden A. Single-cell messenger RNA sequencing reveals rare
intestinal cell types. Nature. 2015;525(7568):251–5.
Jaitin DA, Kenigsberg E, Keren-Shaul H, Elefant N, Paul F, Zaretsky I, Mildner
A, Cohen N, Jung S, Tanay A, et al. Massively parallel single-cell RNA-seq for
marker-free decomposition of tissues into cell types. Science. 2014;
343(6172):776–9.
Zeisel A, Muñoz-Manchado AB, Codeluppi S, Lönnerberg P, La Manno G,
Juréus A, Marques S, Munguba H, He L, Betsholtz C, et al. Brain structure.
Cell types in the mouse cortex and hippocampus revealed by single-cell
RNA-seq. Science. 2015;347(6226):1138–42.
Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, Gravel S, McGee S, Do
R, Liu X, Jun G, et al. Evolution and functional impact of rare coding variation
from deep sequencing of human exomes. Science. 2012;337(6090):64–9.
Gill R, Cheung YH, Shen Y, Lanzano P, Mirza NM, Ten S, Maclaren NK,
Motaghedi R, Han JC, Yanovski JA, et al. Whole-exome sequencing identifies
novel LEPR mutations in individuals with severe early onset obesity. Obesity.
2014;22(2):576–84.
Ku C-S, Tan EK, Cooper DN. From the periphery to Centre stage: de novo
single nucleotide variants play a key role in human genetic disease. J Med
Genet. 2013;50(4):203–11.
Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O'DonnellLuria AH, Ware JS, Hill AJ, Cummings BB, et al. Analysis of protein-coding
genetic variation in 60,706 humans. Nature. 2016;536(7616):285–91.
Sheng Q, Zhao S, Li CI, Shyr Y, Guo Y. Practicability of detecting somatic
point mutation from RNA high throughput sequencing data. Genomics.
2016;107(5):163–9.
Xu C. A review of somatic single nucleotide variant calling algorithms for nextgeneration sequencing data. Comput Struct Biotechnol J. 2018;16:15–24.
Zafar H, Wang Y, Nakhleh L, Navin N, Chen K. Monovar: single-nucleotide
variant detection in single cells. Nat Methods. 2016;13(6):505–7.
Borel C, Ferreira PG, Santoni F, Delaneau O, Fort A, Popadin KY, Garieri M,
Falconnet E, Ribaux P, Guipponi M, et al. Biased allelic expression in human
primary fibroblast single cells. Am J Hum Genet. 2015;96(1):70–80.
Garrison E, Marth G: Haplotype-based variant detection from short-read
sequencing. 2012.
Poplin R, Ruano-Rubio V, DePristo MA, Fennell TJ, Carneiro MO, Van der
Auwera GA, Kling DE, Gauthier LD, Levy-Moonshine A, Roazen D et al: Scaling
accurate genetic variant discovery to tens of thousands of samples. 2017.
DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis
AA, del Angel G, Rivas MA, Hanna M, et al. A framework for variation
discovery and genotyping using next-generation DNA sequencing data. Nat
Genet. 2011;43(5):491–8.
Rimmer A, Phan H, Mathieson I, Iqbal Z, Twigg SRF, Consortium WGS, Wilkie
AOM, McVean G, Lunter G. Integrating mapping-, assembly- and haplotypebased approaches for calling variants in clinical sequencing applications.
Nat Genet. 2014;46(8):912–8.
Wang Y, Navin NE. Advances and applications of single-cell sequencing
technologies. Mol Cell. 2015;58(4):598–609.
Cornish A, Roychoudhury S, Sarma K, Pramanik S, Bhakat K, Dudley A, Mishra
NK, Guda C: Red Panda: A novel method for detecting variants in single-cell
RNA sequencing. bioRxiv 2020:2020.2001.2008.898874.
Xu J: Preparation, culture, and immortalization of mouse embryonic
fibroblasts. Curr Protoc Mol Biol 2005, Chapter 28:Unit 28.21.
Patro R, Mount SM, Kingsford C. Sailfish enables alignment-free isoform
quantification from RNA-seq reads using lightweight algorithms. Nat
Biotechnol. 2014;32(5):462–4.
Li H. A statistical framework for SNP calling, mutation discovery, association
mapping and population genetical parameter estimation from sequencing
data. Bioinformatics. 2011;27(21):2987–93.
Yan H. Allelic variation in human gene expression. Science. 2002;297(5584):
1143–3.
Gregg C, Zhang J, Weissbourd B, Luo S, Schroth GP, Haig D, Dulac C. Highresolution analysis of parent-of-origin allelic expression in the mouse brain.
Science. 2010;329(5992):643–8.

Cornish et al. BMC Genomics 2020, 21(Suppl 11):830

31. Marinov GK, Williams BA, McCue K, Schroth GP, Gertz J, Myers RM, Wold BJ.
From single-cell to cell-pool transcriptomes: stochasticity in gene expression
and RNA splicing. Genome Res. 2014;24(3):496–510.
32. Deng Q, Ramsköld D, Reinius B, Sandberg R. Single-cell RNA-seq reveals
dynamic, random monoallelic gene expression in mammalian cells. Science.
2014;343(6167):193–6.
33. Gimelbrant A, Hutchinson JN, Thompson BR, Chess A. Widespread
monoallelic expression on human autosomes. Science. 2007;318(5853):
1136–40.
34. Cornish A, Guda C. A comparison of variant calling pipelines using genome
in a bottle as a reference. Biomed Res Int. 2015;2015:1–11.
35. Dewey FE, Murray MF, Overton JD, Habegger L, Leader JB, Fetterolf SN,
O'Dushlaine C, Van Hout CV, Staples J, Gonzaga-Jauregui C, et al.
Distribution and clinical impact of functional variants in 50,726 wholeexome sequences from the DiscovEHR study. Science. 2016:354(6319):
aaf6814.
36. Genomes Project C, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin
RM, Gibbs RA, Hurles ME, McVean GA. A map of human genome variation
from population-scale sequencing. Nature. 2010;467(7319):1061–73.
37. Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, Zumbo P, Nayir A, Bakkaloğlu A,
Özen S, Sanjad S, et al. Genetic diagnosis by whole exome capture and
massively parallel DNA sequencing. Proc Natl Acad Sci. 2009;106(45):19096–101.
38. Sandmann S, de Graaf AO, van der Reijden BA, Jansen JH, Dugas M. GLMbased optimization of NGS data analysis: a case study of Roche 454, ion
torrent PGM and Illumina NextSeq sequencing data. PLoS One. 2017;12(2):
e0171983.
39. Zappia L, Phipson B, Oshlack A. Splatter: simulation of single-cell RNA
sequencing data. Genome Biol. 2017;18(1):174.
40. Risso D, Perraudeau F, Gribkova S, Dudoit S, Vert J-P. A general and flexible
method for signal extraction from single-cell RNA-seq data. Nat Commun.
2018;9(1):284.
41. Severson DT, Owen RP, White MJ, Lu X, Schuster-Böckler B. BEARscc
determines robustness of single-cell clusters using simulated technical
replicates. Nat Commun. 2018;9(1):1187.
42. Xiao Z, Cheng G, Jiao Y, Pan C, Li R, Jia D, Zhu J, Wu C, Zheng M, Jia J.
Holo-Seq: single-cell sequencing of holo-transcriptome. Genome Biol. 2018;
19(1):163.
43. Macaulay IC, Haerty W, Kumar P, Li YI, Hu TX, Teng MJ, Goolam M, Saurat N,
Coupland P, Shirley LM, et al. G&T-seq: parallel sequencing of single-cell
genomes and transcriptomes. Nat Methods. 2015;12(6):519–22.

Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.

Page 14 of 14

